Fusion Pharmaceuticals Inc.
Fusion Pharmaceuticals Inc.（FUSN）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
fusn · 股价预测 · 15 位分析师（近3月）· FMP · 更新于 2025年4月25日
分析师评级与共识
基于过去 3 个月内 15 位华尔街分析师
Hold
15 位分析师
共识
评级分布
12 个月目标价
High
$21.00
Consensus
$15.25
-29.2% upside
Low
$6.00
Median: $17 · Last Close: $21.55
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$15.25
-29.2% upside
High Target
$21
-2.6%
Low Target
$6
-72.2%
Current Price
$21.55
as of today
Based on analyst price targets, the FUSN stock price prediction for the next 12 months ranges from $6 to $21. The consensus FUSN price forecast of $15.25 implies -29.2% upside from the current price of $21.55.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $21.55 | ↑ 0.00% |
1-day model range: $21.54–$21.56. Peak: $21.56 (+0.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $18 | -16.5% |
| 2028 | $16 | -24.1% |
| 2029 | $16 | -27.8% |
| 2030 | $15 | -29.8% |
| 2031 | — | -30.9% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · FUSN · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-04-16 | TD Cowen | Downgrade ↓ | Buy→Hold |
| 2024-03-21 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2024-03-21 | Wedbush | Maintains | Neutral→Neutral |
| 2024-03-20 | Truist Securities | Downgrade ↓ | Buy→Hold |
| 2024-03-20 | Raymond James | Downgrade ↓ | Strong Buy→Market Perform |
| 2024-03-20 | JonesTrading | Downgrade ↓ | Buy→Hold |
| 2024-03-20 | RBC Capital | Downgrade ↓ | Outperform→Sector Perform |
| 2024-03-20 | B. Riley Securities | Downgrade ↓ | Buy→Neutral |
| 2024-03-19 | Brookline Capital | Downgrade ↓ | Buy→Hold |
| 2024-03-19 | Jefferies | Downgrade ↓ | Buy→Hold |
Wall Street analysts have recently issued updated ratings on Fusion Pharmaceuticals Inc. (FUSN) stock. Of the recent 47 rating actions, 1 were upgrades and 13 were downgrades. 15 analysts currently cover FUSN.
分析师推荐趋势
FUSN analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$4M
↓ 64.2% YoY
Revenue Next Year
$1M
↓ 86.3% YoY
EPS This Year
$-1.44
EPS Next Year
$-1.60
↑ 11.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast FUSN EPS of $-1.44 for the current fiscal year, based on estimates from 7 analysts. The FUSN revenue forecast is $4M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
FUSN 股价预测由两类独立数据源支撑：来自 15 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。FUSN 的共识目标价为 $15.25（-29.2% 上行空间），分析师共识为 Hold。
FUSN 的短期预测（明日）为 $21.55（+0.00%）。 FUSN 对 2027 年的股价预测均值为 $18。 FUSN 对 2030 年的预测区间为 $15–$15。
Fusion Pharmaceuticals Inc. 在 NASDAQ 上市，代码 FUSN。FUSN 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 27% 对应 Hold 共识。
常见问题
FUSN 预测 · 8 个问题根据 15 位华尔街分析师，FUSN 的 12 个月平均目标价为 $15.25，最高 $21.00、最低 $6.00。若有图表，中位目标价可在上方查看。相对当前价 $21.55，隐含约 -29.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.